Holen Sie sich die Stockscreener-App
5.47
6.42%
0.33
Handel nachbörslich:
5.49
0.02
+0.37%
Schlusskurs vom Vortag:
$5.14
Offen:
$5.1
24-Stunden-Volumen:
335.53K
Relative Volume:
1.18
Marktkapitalisierung:
$92.75M
Einnahmen:
$53.74M
Nettoeinkommen (Verlust:
$33.24M
KGV:
1.7078
EPS:
3.203
Netto-Cashflow:
$-33.54M
1W Leistung:
-0.55%
1M Leistung:
-3.01%
6M Leistung:
+135.78%
1J Leistung:
+255.19%
1-Tages-Spanne:
$5.02
$5.52
1-Wochen-Bereich:
$4.97
$5.70
52-Wochen-Spanne:
$1.345
$8.045
Q 32 Bio Inc Stock (QTTB) Company Profile
Firmenname
Q 32 Bio Inc
Sektor
Branche
Telefon
781-999-0232
Adresse
830 WINTER STREET, WALTHAM
Compare QTTB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
5.47 | 87.16M | 53.74M | 33.24M | -33.54M | 3.203 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-02-11 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2025-02-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-12-11 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-12-11 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-10-24 | Eingeleitet | Raymond James | Strong Buy |
| 2024-09-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-17 | Eingeleitet | Guggenheim | Buy |
| 2024-05-21 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-02 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-02-22 | Bestätigt | BTIG Research | Neutral |
| 2022-02-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-02-22 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-12-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Buy |
| 2020-05-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-03-16 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-02-24 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-11-01 | Eingeleitet | Oppenheimer | Perform |
| 2019-09-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-04-12 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Q 32 Bio Inc Aktie (QTTB) Neueste Nachrichten
Q32 Bio gears up to report Q1 earnings: What's in the cards? - MSN
Q32 Bio Inc. posts first quarter 2026 financial results and issues corporate update - Traders Union
Q32 Bio Inc. 1Q 2026: Net loss $(7.61M), EPS $(0.54) — 10-Q Summary - TradingView
Q32 Bio Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Q32 Bio: Q1 Earnings Snapshot - KVUE
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update - PR Newswire
Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards? - sharewise.com
Q32 Bio (QTTB) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Q32 Bio (NASDAQ:QTTB) Trading Down 3.8%What's Next? - MarketBeat
Q32 Bio Expands ATM Offering With New $75M Prospectus - The Globe and Mail
QTTB Price Today: Q32 Bio Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Q32 Bio files prospectus for up to $75 million at-the-market share offering - Investing.com UK
Q32 Bio Inc files additional prospectus to offer up to $75 million of common stock - marketscreener.com
Q32 Bio files $75M prospectus supplement after exhausting $14.2M ATM offering - TradingView
Q32 Bio (QTTB) Stock: Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesRisk Event - Cổng thông tin điện tử tỉnh Lào Cai
Momentum Outlook | Q32 Bio Inc. delivers 515.8% EPS surprise topping estimatesPro Level Trade Signals - Cổng thông tin điện tử tỉnh Lào Cai
Q32 Bio (QTTB) Stock Insider Ownership (Bearish Sentiment) 2026-04-22Social Buy Zones - Xã Vĩnh Công
Q32 Bio (QTTB) Stock: Buy Decision Breakdown (Bullish Sentiment) 2026-04-20Blue Chip Stocks - Xã Vĩnh Công
Pullback Watch: Will Q32 Bio Inc benefit from geopolitical trendsStop Loss & Stock Portfolio Risk Management - baoquankhu1.vn
Market Pulse: Will Q32 Bio Inc stock benefit from M A2026 PostEarnings & Stepwise Trade Signal Guides - baoquankhu1.vn
Is Q32 Bio (QTTB) Stock Trending Up | Price at $5.09, Down 6.95%Undervalued Stocks - Xã Thanh Hà
Q32 Bio Inc. schedules fireside chat at upcoming Needham healthcare conference - Traders Union
Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference - Weekly Voice
Q32 Bio management goes live online April 15 at Needham conference - Stock Titan
Q32 Bio (NASDAQ:QTTB) Shares Up 4.6% – Should You Buy? - Defense World
Will Q32 Bio (QTTB) Stock Outperform Peers | Price at $5.83, Down 8.62%Trader Community Insights - Newser
Does Q32 Bio (QTTB) Have the Potential to Rally 97.66% as Wall Street Analysts Expect? - Yahoo Finance
Q32 Bio: Bempikibart Keeps The Alopecia Areata Bull Case Alive (NASDAQ:QTTB) - Seeking Alpha
Q32 Bio Launches Flexible $14.2 Million ATM Program - The Globe and Mail
Q32 Bio enters $14.2 million at-the-market equity sales agreement with Cantor Fitzgerald - Investing.com
If You Invested $1,000 in Q32 BIO INC (QTTB) - stocktitan.net
Q32 Bio (QTTB) CSO granted 37,500 RSUs and updates holdings - Stock Titan
Q32 Bio (QTTB) awards 53,250 RSUs to its CFO and President - Stock Titan
Q32 Bio (QTTB) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Best Momentum Stocks to Buy for March 19th - theglobeandmail.com
Q32 Bio (NASDAQ:QTTB) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
Best Momentum Stocks to Buy for March 13th - The Globe and Mail
Q32 Bio Hits New HighRegrowth Signals? - RTTNews
Q32 Bio, Inc. Experiences Comprehensive Evaluation Adjustment Amid Financial Landscape Changes - Markets Mojo
Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI) - The Globe and Mail
FY2026 Earnings Estimate for Q32 Bio Issued By HC Wainwright - MarketBeat
Q32 Bio Faces Governance Backlash and Rising Costs After 2025 Stock Option Repricing - The Globe and Mail
What is HC Wainwright’s Forecast for Q32 Bio Q1 Earnings? - Defense World
Q1 Earnings Estimate for Q32 Bio Issued By HC Wainwright - MarketBeat
Q32 Bio Reports Q4 2025 Financial Results, Highlights SIGNAL-AA Trial Progress and Strong Financial Runway into 2027 - Minichart
Finanzdaten der Q 32 Bio Inc-Aktie (QTTB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):